We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Citing GlaxoSmithKline (GSK) for false and misleading claims about three of its hepatitis vaccinations, as well as a non-GSK influenza vaccine, the FDA’s Center for Biologics Evaluation and Research (CBER) has issued a warning letter to the company.